Thermo Fisher Scientific (TMO) Current Assets (2009 - 2026)

Thermo Fisher Scientific has reported Current Assets for 18 years, with the latest figure at $23.4 billion in Q2 2026.

• Current Assets for Q2 2026 came in at $23.4 billion, down 4.96% year-over-year; the trailing twelve-month figure through Jun 2026 was $23.4 billion (down 4.96% YoY), and the FY2025 annual result was $28.7 billion, up 29.68% from the prior year.
• Current Assets grew to $23.4 billion in Q2 2026, from $22.3 billion in the prior quarter.
• Over five years, Current Assets peaked at $28.7 billion in Q4 2025 and troughed at $18.1 billion in Q3 2022.
• A 5-year average of $22.7 billion and a median of $23.2 billion in 2023 frame the typical range for Current Assets.
• The widest annual swing landed in 2022, when Current Assets dropped 21.94%; it then increased 29.68% in 2025.
• A 5-year view of Current Assets shows it stood at $25.2 billion in 2022, then decreased by 2.54% to $24.6 billion in 2023, then fell by 9.97% to $22.1 billion in 2024, then increased by 29.68% to $28.7 billion in 2025, then decreased by 18.61% to $23.4 billion in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $23.4 billion in Q2 2026, $22.3 billion in Q1 2026, and $28.7 billion in Q4 2025.